[167-POS] : The human endogenous protection system against cell-free hemoglobin is overwhelmed during preeclampsia - New biomarkers and potential targets for therapy.
To study cell-free fetal hemoglobin (HbF) and the heme-scavenger α1- microglobulin (A1M) in patients with manifest preeclampsia (PE) and how these proteins performed as possible biomarkers of PE and adverse maternal and fetal outcomes.
